Ads
related to: Vertex PharmaceuticalsLearn About Our Efforts to Improve the Lives of Patients, Employees and Our Communities. Stay Current on All Things Vertex and Hear From Leaders on Topics That Matter Most to Us.
- Contact Us
Find all the ways to reach us
for the information you need.
- News
Stay current on all things Vertex
and discover the latest news.
- Our Company
Learn about our mission and
the values that drive us.
- Our Unique Approach
See What Makes Us Unique
And How We Put Science First.
- Contact Us
Regulatory intelligence for more than 150 countries, supporting you around the globe. Small Molecule APIs, Large Molecule Biologics, API's & Intermediates, SIs, and OSDs.
Search results
Vertex is a biotechnology company that develops and commercializes drugs for serious diseases. Learn about its latest news, acquisitions, financial results, corporate responsibility and pain program.
- Our Approved Medicines
Our Approved Medicines - Vertex Pharmaceuticals | Home
- Our Company
Vertex Pharmaceuticals strikes at the core of serious...
- Benefits
Vertex Pharmaceuticals provides a range of comprehensive...
- Our Science
Our Science - Vertex Pharmaceuticals | Home
- Patients
Patients - Vertex Pharmaceuticals | Home
- Investor Relations
The Investor Relations website contains information about...
- Our Approved Medicines
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
Dec 8, 2023 · CASGEVY is a CRISPR/Cas9 genome-edited cell therapy for sickle cell disease (SCD) that offers the potential of a functional cure by reducing vaso-occlusive crises. Vertex leads global development and commercialization of CASGEVY, with support from CRISPR Therapeutics.
Vertex is developing innovative medicines for cystic fibrosis, pain, sickle cell disease, beta thalassemia and other serious diseases. See the list of programs in different phases of clinical research and outlicensed to other companies.
Jan 30, 2024 · Vertex announces positive results from Phase 3 program for VX-548, a selective NaV1.8 inhibitor for moderate-to-severe acute pain. VX-548 showed statistically significant improvement in pain compared to placebo and was safe and well tolerated in surgical and non-surgical pain conditions.
People also ask
What does vertex do?
Where is vertex located?
Who is Vertex Pharmaceuticals?
What diseases does vertex treat?
Ads
related to: Vertex PharmaceuticalsLearn About Our Efforts to Improve the Lives of Patients, Employees and Our Communities. Stay Current on All Things Vertex and Hear From Leaders on Topics That Matter Most to Us.
Regulatory intelligence for more than 150 countries, supporting you around the globe. Small Molecule APIs, Large Molecule Biologics, API's & Intermediates, SIs, and OSDs.
Types:
